Clinical efficacy of local targeted chemotherapy for triple-negative breast cancer

Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007; 109: 1721-8.10.1002/cncr.22618Search in Google Scholar

Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol 2007; 8: 235-44.10.1016/S1470-2045(07)70074-8Search in Google Scholar

Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010, 363: 1938-48.10.1056/NEJMra100138921067385Search in Google Scholar

Ovcaricek T, Frkovic SG, Matos E, Mozina B, Borstnar S. Triple negative breast cancer - prognostic factors and survival. Radiol Oncol 2011; 45: 46-52.10.2478/v10019-010-0054-4342372122933934Search in Google Scholar

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007; 109: 25-32.10.1002/cncr.2238117146782Search in Google Scholar

Billar JA, Dueck AC, Stucky CC, Gray RJ, Wasif N, Northfelt DW, et al. Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol 2010; 17(Suppl 3): 384-90.10.1245/s10434-010-1260-420853062Search in Google Scholar

Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, et al. Poly(ADP-Ribose) polymerase inhibition: "Targeted" therapy for triple-negative breast cancer. Clin Cancer Res 2010; 16: 4702-10.10.1158/1078-0432.CCR-10-0939294860720858840Search in Google Scholar

Wang XM, He JS, Tong JM. Clinical application of preoperative superselective intra-arterial chemotherapy in the treatment of late breast cancer cases. Journal of Surgery Concepts & Practice 2006; 11: 136-8.Search in Google Scholar

Zuo WS. Modern molecular oncology of breast cancer. 2nd edition. Shandong: Shandong Science & Technology Press; 2006. p. 974-9.Search in Google Scholar

Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, Zahm DM, et al. Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. Breast Cancer Res Treat 2010; 124: 133-40.10.1007/s10549-010-1103-920697801Search in Google Scholar

Yi SY, Ahn JS, Uhm JE, Lim do H, Ji SH, Jun HJ, et al. Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype. BMC Cancer 2010; 10: 527.10.1186/1471-2407-10-527297228220920367Search in Google Scholar

Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol 2006; 19: 617-21.10.1038/modpathol.380057016528377Search in Google Scholar

Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer sub-types. Clin Cancer Res 2007; 13: 2329-34.10.1158/1078-0432.CCR-06-1109Search in Google Scholar

Maegawa RO, Tang SC. Triple-negative breast cancer: unique biology and its management. Cancer Invest 2010; 28: 878-83.10.3109/07357907.2010.483507Search in Google Scholar

Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009; 43: 1-8.10.2478/v10019-009-0004-1Search in Google Scholar

Maurer CA, Borner M, Buchler MW. Regional chemotherapy of gastrointestinal cancer. Digestive Surg 1997; 14: 9-22.10.1159/000172505Search in Google Scholar

Miura T, Takeuchi I, Kikuoka S, Miura T. Intra-arterial infusion chemotherapy for advanced breast cancer - 5 cases of marked response. Gan To Kagaku Ryoho 2009; 36: 2108-10.Search in Google Scholar

Vanel D. Interventional radiology: the new daily work of the breast radiologist. Eur J Radiol 2002; 42: 1.10.1016/S0720-048X(02)00039-6Search in Google Scholar

Pacetti P, Mambrini A, Paolucci R, Sanguinetti F, Palmieri B, Della Seta R, et al. Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer. In Vivo 2006; 20: 761-4.Search in Google Scholar

Takizawa K, Shimamoto H, Ogawa Y, Yoshimatsu M, Yagihashi K, Nakajima Y, et al. Development of a new subclavian arterial infusion chemotherapy method for locally or recurrent advanced breast cancer using an implanted catheter-port system after redistribution of arterial tumor supply. Cardiovasc Inter Rad 2009; 32: 1059-66.10.1007/s00270-009-9510-119238484Search in Google Scholar